Researchers at Albert Einstein College of Medicine have found that when human papillomavirus (HPV)-16 is detected in peoples' mouths, they are 22 times more likely than those without HPV-16 to develop ...

Head and neck cancer symptoms vary by tumor location, often presenting as a neck lump or voice changes. Smoking and HPV are major risk factors; cessation and vaccination are crucial preventive ...

Head and neck squamous cell carcinoma (HNSCC) remains a globally prevalent malignancy with high morbidity and mortality. Despite therapeutic advances, patient outcomes are hindered by tumor ...

Head and neck cancers represent 4% of U.S. cancer cases, with significant mortality rates, highlighting the need for awareness and early detection. These cancers affect multiple anatomical sites, ...

Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...

Head and neck cancers affect the tissues of the mouth, throat, sinuses, and surrounding areas. They can impact crucial functions like breathing, swallowing, and talking. There are several types of ...

Lead programme based on a first-in-class small-molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV-positive head and neck cancer Programme has demonstrated strong in ...

The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...

Adding neoadjuvant and adjuvant pembrolizumab to the standard of care significantly improved event-free survival in patients with previously untreated, locally advanced head and neck squamous cell ...